Cancer Weekly articles from January 1991

Cancer Weekly archives from January 1991

Anti-tumor effects of ImuVert published. (anticancer biological response modifier) (Cell Technology-Oncotech)
January 14, 1991... Cell Technology-Oncotech Cell Technology, Inc., a Boulder, Colorado-based biotechnology firm specializing in the development of biologic response modifier (BRM) technology, and Oncotech, Inc., Irvine, California, a cancer research...

Prediction of radiation therapy success topic of research. (University of California, Riverside)
January 14, 1991... University of California, Riverside Cancer research at the University of California, Riverside, (UCR) may yield molecular probes which can predict the success or failure of radiation therapy. "About one-third of cancer patients...

Progress reported in culturing human B-cells; work may lead to new way of producing monoclonal antibodies. (Schering-Plough Corp.) (France)
January 14, 1991... France Scientists at Schering-Plough Corporation's Laboratory for Immunological Research, Dardilly, France, announced that they have cultured antibody-producing human white blood cells, called B-cells, in the test tube. The...

Glaxo receives final approval for drug to prevent chemotherapy-induced nausea. (ondansetron hydrochloride, to be marketed as Zofran) (U.S. Food and Drug Administration)
January 14, 1991... U.S. FDA A new drug for the prevention of nausea and vomiting in cancer patients undergoing chemotherapy has received final approval from the U.S. Food and Drug Administration (FDA), Glaxo Inc., a subsidiary of U.K.'s Glaxo Holdings...

Imaging device installed to measure health of body organs. (positron emission tomography imaging) (Palo Alto Veterans Administration Medical Center)
January 14, 1991... Palo Alto Veterans Administration Medical Center Northern California's first clinical PET scanner, a medical imaging device that shows not only whether an organ is physically damaged but also whether it's functioning normally, has been...

Clinical trial of Onconase, experimental anti-cancer drug announced. (Alfacell)
January 14, 1991... Alfacell Alfacell Corp., Bloomfield, New Jersey, announced that the first Phase II clinical trial of Onconase, the company's experimental anticancer drug, has begun at The Thompson Cancer Survival Center in Knoxville, Tenn. ...

Non-invasive technique removes brain tumors without surgery. (University of California, Los Angeles)
January 14, 1991... University of California, Los Angeles With the development of non-invasive radiosurgery, it is possible without surgical incisions to diminish or destroy brain tumors and vascular malformations previously considered untreatable because...

U.S. Bioscience grants Kanebo Ltd. marketing rights for anticancer compound. (Hexalen, anti-ovarian cancer agent) (Japan)
January 14, 1991... Japan U.S. Bioscience Inc., a pharmaceutical company specializing in the development and commercialization of anticancer compounds, announced that an agreement in principle was reached with Kanebo Ltd., of Osaka, Japan, under which...

Pact to develop carbohydrate-based therapeutics. (Genentech and Glycomed)
January 14, 1991... Genentech and Glycomed Genentech Inc. and Glycomed Inc. announced they have signed an agreement for a $15 million research collaboration to develop carbohydrate-based therapeutics in the rapidly emerging field of cell adhesion molecules....

Activists and utilities getting together to resolve the EMF dilemma. (association of electromagnetic fields or frequencies with leukemias and lymphomas) (California)
January 14, 1991... California With scientists focusing studies on the possible association of EMF (electromagnetic fields or electromagnetic frequencies) with human leukemias and lymphomas, the electric utilities are responding to community concerns. ...

Cancer continues as leading cause of death. (Japan)
January 14, 1991... Japan The main cause of death in Japan in 1990 was cancer, according to a report released by the Japan Health and Welfare Ministry. The report, released earlier this month, said 826,000 people died in Japan in 1990. It said...

Pills to prevent thyroid cancer distributed near nuclear plant. (Bohunice nuclear plant in the Slovak republic) (Austria, Czechoslovakia)
January 14, 1991... Austria, Czechoslovakia Potassium iodide pills to prevent thyroid cancer are being distributed in Czechoslovakia and Austria near Bohunice nuclear plant in the Slovak republic. The Czech daily Zemedelsky Noviny said the medicine is...

Benzene in Perrier cut sales by half last year. (France)
January 14, 1991... France Jacques Vincent, chairman of Source Perrier SA, Paris, told the business newspaper La Tribune de l'Expansion that the benzene contamination of Perrier reduced U.S. sales by half last year. In February, 1990, Perrier withdrew...

Meat being checked for benzene. (U.S. Department of Agriculture)
January 14, 1991... U.S Department of Agriculture U.S. Department of Agriculture and U.S. Food and Drug Administration officials are reportedly checking parts of the U.S. for benzene contamination of the meat supply. The benzene, which can cause...

Consumers advised to return Mathis Dairy products. (Georgia)
January 14, 1991... Georgia An additional 1,692 gallons of buttermilk produced by Atlanta-based Mathis Dairy bearing the expiration dates January 27 and January 30 have been identified as processed on the same date as other dairy products found to contain...

Caring for the dying child focus of Journal articles. (Ca - A Cancer Journal for Clinicians) (American Cancer Society)
January 14, 1991... American Cancer Society The current issue (November/December 1990) of Ca - A Cancer Journal for Clinicians addresses the aspect of childhood cancer that usually isn't written about - caring for the dying child. Written by two...

Childhood cancer statistics calculated. (University of Texas)
January 14, 1991... University of Texas In the November/December, 1990, issue of Ca - A Cancer Journal for Clinicians, W. Archie Bleyer, MD, Head of the Division of Pediatrics at the University of Texas M.D. Anderson Cancer Center, authors an article on...

Success rate good for smokers who quit on their own. (University of California)
January 14, 1991... University of California The chances for success are pretty good for smokers who quit on their own, say smoking cessation experts at University of California, Los Angeles (UCLA), Jonsson Comprehensive Cancer Center. In a study of...

Teenage girls having more sex more often. (United States Centers for Disease Control)
January 14, 1991... U.S. CDC Fifteen-year-old females are more than five times as likely to be active sexually than those the same age ten years ago, and more than half the women in the U.S. age 15 through 19 have had premarital sex, according to the U.S....

Radiation exposure study responsibility moves from Department of Energy. (U.S. Centers for Disease Control)
January 14, 1991... U.S. CDC The U.S. Centers for Disease Control (CDC) has assumed responsibility from the U.S. Department of Energy (DOE) for studying radiation exposure from nuclear weapons installations. The radiation exposure among government...

$8.1 million venture capital financing completed. (Cellular Transplants)
January 14, 1991... Cellular Transplants Cellular Transplants Inc., Providence, Rhode Island, announced that it has completed an $8.1 million second-round financing to continue the development of products for the treatment of Parkinson's disease and...

Biotechnology sales could reach $4 billion by mid-1990s. (Hambrecht & Quist)
January 14, 1991... Hambrecht & Quist Product sales in biotechnology could reach $4 billion by the mid-1990s, David H. MacCallum, managing director of healthcare at Hambrecht & Quist, Inc., said at the opening of the firm's Ninth Annual Life Sciences...

Atlanta judge's opinion could cost nation's hospitals billions in anti-trust settlements. (11th Circuit Federal Court of Appeals)
January 14, 1991... 11th Circuit Federal Court of Appeals A precedent-setting decision by the 11th Circuit Federal Court of Appeals in Atlanta issued December 28, 1990, could pave the way for multi-million dollar claims against major hospitals in every area...

Attorney General Preate says Pittsburgh charity misappropriated more than $100,000. (Ernie Preate Jr., Godspeed House) (Pennsylvania)
January 14, 1991... Pennsylvania Godspeed House, a Pittsburgh charity that claims to serve individuals with serious illnesses, misappropriated more than $100,000 in contributions and other funds, Attorney General Ernie Preate Jr. charges in a suit filed...

High precision photon radiotherapy of head and neck tumors by means of an integrated stereotactic and 3D planning system. (Research Report)
January 14, 1991... AUTHORS: G. Gademann, W. Schlegel, G. Becker, J. Romahn, K.H. Hover, O. Pastyr, G. van Kaick and M. Wannenmacher. German Cancer Research Center, Heidelberg, Germany. According to the authors' abstract of a presentation to the American...

Bulky endocervical carcinomas of the uterine cervix: a 23-year experience at the M.D. Anderson Cancer Center. (Research Report)
January 14, 1991... AUTHORS: W.W. Thoms, Jr., P.J. Eifel, L. Delclos, J.T. Wharton and M.J. Oswald. M.D. Anderson Cancer Center, Houston, Tex. According to the authors' abstract of a presentation to the American Society for Therapeutic Radiology and...

The design and use of scattering foil compensators in electron beam therapy. (Research Report)
January 14, 1991... AUTHORS: Kenneth Ulin and Madeline Palisca. Tufts-New England Medical Center, Boston, Mass. According to the authors' abstract of a presentation to the American Society for Therapeutic Radiology and Oncology, held in Miami, Fla., "A...

Aerosolized interferon-gamma inhalation therapy for adult T-cell leukemia/lymphoma. (Research Report)
January 14, 1991... AUTHORS: M. Tara, T. Okadome and K. Niiha, Kagoshima City Hospital; and M. Johnosono, I. Maruyama and M. Osame, Kagoshima University, Kagoshima, Japan. According to the abstract submitted by the authors to the joint meeting of the...

Prophylactic Acyclovir (ACV) may prevent lymphoma in HIV-infected patients (HIP). (Research Report)
January 14, 1991... AUTHORS: D.W. Blayney, J.T. Lee, D.D. Brown, M.E. King, L.D. Bosserman and C.A. Presant. Wilshire Oncology Medical Group, Renaissance Immune Suppression Unit, West Covina, Calif. According to the abstract submitted by the authors to the...

Fluorouracil enhances azidothymidine anti-retroviral activity in vivo in the Rauscher murine leukemia virus model. (Research Report )
January 14, 1991... AUTHORS: J.W. Darnowski, P. Tosi and P. Calabresi. Department of Medicine, Brown University, and Roger Williams General Hospital, Providence, R.I. According to the abstract submitted by the authors to the joint meeting of the...

A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. (Periodical Report)
January 14, 1991... SOURCE: Cancer, January 1, 1991; 67(1):14-19. Weekly cisplatin treatment does not appear to increase the efficacy of protracted infusion 5-fluorouracil in the treatment of colorectal cancer patients, according to a report of the...

A phase II clinical trial of carboplatin infusion in high-risk acute nonlymphoblastic leukemia. (chemotherapy) (Periodical Report)
January 14, 1991... SOURCE: Journal of Clinical Oncology, January, 1991; 9(1):39-43. The platinum drug carboplatin appears to be an effective second-line treatment for acute nonlymphoblastic leukemia patients, and may also have significant first-line...

Phase I trial of piritrexim capsules using prolonged, low-dose oral administration for the treatment of advanced malignancies. (drug) (Periodical Report)
January 14, 1991... SOURCE: Journal of the National Cancer Institute, January 2, 1991; 83(1):51-55. The folate antagonist piritrexim can be safely given at a dosage of 25 mg three times a day for five days during three consecutive weeks followed by one...

Benzylacyclouridine reverses azidothymidine-induced marrow suppression without impairment of anti-human immunodeficiency virus activity; and, Differential effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice. (Periodical Report)
January 14, 1991... SOURCE: Blood, December 1, 1990; 76(11):2210-2215 and 2216-2221. A compound that increases plasma and tissue uridine concentrations can reduce the toxicity of AZT without reducing its antiretroviral efficacy, animal studies show. ...

Premarital sexual experience among adolescent women - United States, 1970-1988. (Periodical Report)
January 14, 1991... SOURCE: Morbidity and Mortality Weekly Report, January 3, 1991. "The initiation of sexual intercourse early in life is associated with an increased number of sex partners and a greater risk for sexually transmitted diseases (STDs). This...

Link between cancer and electricity debated. (U.S. Environmental Protection Agency)
January 21, 1991... U.S. EPA A U.S. Environmental Protection Agency (EPA) scientific advisory board heard testimony concerning the relationship between cancer and electricity (see also Department: News Report, December 24, 1990. The EPA told the...

Breast conservation therapy endorsed. (American Medical Association)
January 21, 1991... American Medical Association Breast conservation treatment is an appropriate method of primary therapy for most women with early-stage breast cancer (clinical stage I and II), according to an article published in the January 16, 1991,...

New Medicare rule covers screening mammography, includes quality standards. (American College of Radiology)
January 21, 1991... American College of Radiology Mammography screening for breast cancer will be covered by Medicare under a federal rule published this month. Women included are those over 65 and those younger women qualifying for Medicare benefits due...

Lockheed wins $39 million contract for supercomputers to search for cancer, AIDS cures. (Lockheed Integrated Solutions Co.) (U.S. National Cancer Institute)
January 21, 1991... U.S. NCI The National Cancer Institute (NCI) has awarded a five-year, $39 million contract to Lockheed Integrated Solutions Co. (LISC) to update the institute's Advanced Scientific Computing Laboratory. The upgrade will provide a...

Nonsurgical treatment for liver cancer to be marketed. (Theragenics Corp. to market TheraSphere) (Health and Welfare Canada)
January 21, 1991... Canada Health and Welfare Canada has authorized use of TheraSphere, a nonsurgical liver cancer treatment, which will be marketed to medical facilities in Canada by Theragenics Corp., Norcross (Atlanta), Georgia. Nordion...

Yamanouchi Pharmaceutical to start European tests of cancer drug. (drugs to relieve nausea resulting from anticancer drugs) (Japan)
January 21, 1991... Japan Clinical tests to relieve nausea resulting from anticancer drugs will begin in Europe in 1991. The anti-nausea drug testing will be conducted by Yamanouchi Pharmaceutical Co. Ltd., Tokyo, Japan. European marketing for...

U.S. FDA grants permission to export cancer treatment enhancement. (Food and Drug Administration approves Courier, from Lifecore Biomedical Inc.) (Canada)
January 21, 1991... Canada The U.S. Food and Drug Administration (FDA) has granted permission for Canadian export and distribution of Courier, a chemotherapy enhancement agent. Courier is a product of Lifecore Biomedical, Inc., Minneapolis, Minnesota....

Enzon files plan for leukemia drug. (PEG-L-asparaginase) (U.S. Food and Drug Administration)
January 21, 1991... U.S. FDA Enzon, Inc., South Plainfield, New Jersey, announced the filing of a Product License Application (PLA) with the Food and Drug Administration (FDA) for PEG-L-asparaginase. Under the specifications of the PLA,...

Researchers report strong link between passive smoking and heart disease. (University of California, San Francisco)
January 21, 1991... University of California, San Francisco Nonsmoking spouses of smokers are 30 percent more likely to die of heart disease than other nonsmokers, according to a new report by two University of California, San Francisco (UCSF), heart...

New regulation requires warning label on Gulf oysters; risk to immune-deficient individuals only. (Gulf of Mexico, risk of Vibrio vulnificus contamination) (California Department of Health Services)
January 21, 1991... California The California Department of Health Services will issue a new regulation, effective March 1, which requires California retailers who sell raw oysters harvested from the Gulf of Mexico to warn persons with compromised immune...

TV helping young cancer patients. (University of Cincinnati Medical Center)
January 21, 1991... University of Cincinnati Medical Center Pediatric cancer patients undergoing radiation therapy often have a hard time dealing with the temporary separation from parents and doctors. Doctors at the Barrett Cancer Center, University...

Blood sent to military for Operation Desert Shield. (Red Cross)
January 21, 1991... Red Cross American Red Cross Blood Services/Atlanta Region responded to its first request from the national American Red Cross to supplement military blood supplies in support of Operation Desert Shield. The Atlanta Region sent 100...

Hispanic communities in U.S. hard hit by AIDS, cancer. (American Medical Association)
January 21, 1991... American Medical Association More than any other U.S. ethnic group, Hispanics are suffering a higher share of ailments such as AIDS and cancer, according to a report in the Journal of the American Medical Association (JAMA). By the...

Agreement for testing Roberts Pharmaceutical drugs for anti-HIV/cancer activity. (U.S. National Cancer Institute)
January 21, 1991... U.S. NCI Roberts Pharmaceutical Corporation reported that it has entered into an agreement with the National Cancer Institute (NCI) to screen Roberts' new drugs for anticancer and anti-HIV activity. Under the terms of the agreement,...

New drug reduces and partially reverses fluorodeoxyuridine and AZT toxicity. (benzylacyclouridine or BAU) (Brown University)
January 21, 1991... Brown University Brown University, Providence, R.I., researchers are seeking FDA approval for clinical trials of a new drug that reduces and partially reverses the toxic effects of AZT in animal studies. The drug,...

Collaboration announced for enhanced frozen red blood cells. (Agouron Pharmaceuticals Inc. and CryoLife Inc.)
January 21, 1991... Agouron and Cryolife Agouron Pharmaceuticals Inc. and CryoLife Inc., announced that they have entered into the second phase of a collaborative effort to develop and commercialize proprietary technology which enhances the viability of...

Presentation to the Hambrecht & Quist Ninth Annual Life Sciences Conference. (Charles A. Baker) (The Liposome Company)
January 21, 1991... The Liposome Company Charles A. Baker, chairman and chief executive officer of The Liposome Company, Inc. updated participants at the Hambrecht & Quist Ninth Annual Life Sciences Conference on Liposome's accomplishments in 1990. He...

Cancer information line expands services, hours. (Cancer Information and Referral Service) (Pittsburgh Cancer Institute)
January 21, 1991... Pittsburgh Cancer Institute The toll-free Cancer Information and Referral Service (CIRS), operated by the Pittsburgh Cancer Institute, has expanded its hours and services. According to Karen Robinson, R.N., M.N., clinical director...

International Conference on Cancer Prevention planned. (International Council for Coordinating Cancer Research)
January 21, 1991... The International Council for Coordinating Cancer Research (ICCCR) will host the First International Conference on Cancer Prevention from February 12-13 in Bethesda, Maryland. According to ICCCR, this is the first time that scientists...

New manual helps physicians form support groups. ("Helping Your Patients Overcome the Effects of Prostate Cancer: A Guide for Establishing Support Groups") (American Foundation of Urologic Diseases)
January 21, 1991... To help prostate cancer patients deal with the emotional trauma that accompanies the disease, ICI Pharma and the American Foundation of Urologic Diseases (AFUD) announced the development of a manual to provide urologists with guidelines to set...

Mirabelli promoted to senior vice president. (Christopher K. Mirabelli) (ISIS Pharmaceuticals)
January 21, 1991... ISIS Pharmaceuticals, Carlsbad, California, announced the promotion of Christopher K. Mirabelli, Ph.D., to senior vice president, research and pre-clinical development. Mirabelli is one of the co-founders of ISIS and has been vice...

Increased first quarter income and revenues reported. (Salick Health Care)
January 21, 1991... Salick Health Care Inc. reported increased revenues and income for its fiscal 1991 first quarter ended November 30, 1990. Net operating revenues rose 8 percent to $16,371,000 from $15,176,000 in the same period a year ago. Net income...

$300,000 going to state as settlement of fund-raising case. (Watson & Hughey Co. and other defendants in deceptive direct-mail solicitation case) (Pennsylvania)
January 21, 1991... A professional fund-raising business, eight of its client organizations and three individuals will pay Pennsylvania $300,000 to settle allegations that they conducted deceptive nationwide direct-mail solicitations, Attorney General Ernie...

Analysis of complications in patients receiving adjuvant irradiation for endometrial carcinoma. (Research Report)
January 21, 1991... AUTHORS: K.M. Greven, R.M. Lenciano, S. Herbert and P.E. Hogan. Bowman Gray School of Medicine, Fox Chase Cancer Center. According to the authors' abstract of a presentation to annual meeting of the American Society for Therapeutic...

Dosimetry and dose specification for a new gynecological brachytherapy applicator. (vaginal cancer) (Research Report)
January 21, 1991... AUTHORS: Eric D. Slessinger, Carlos A. Perez, Perry W. Grigsby and Jeffrey F. Williamson. Washington University School of Medicine, St Louis, Missouri. According to the authors' abstract of a presentation to the annual meeting of the...

Three-dimensional (3-D) treatment planning of intracavitary gynecologic implants: analysis of ten cases and implications for dose specification. (Research Report)
January 21, 1991... AUTHORS: S.L. Schoeppel, M.L. LaVihne, D.L. McShan, B.A. Fraass and J.A. Roberts. The University of Michigan at Ann Arbor. According to the authors' abstract of a presentation to the annual meeting of the American Society for...

Optimization of high dose-rate cervix brachytherapy; part I: dose distribution. (Research Report)
January 21, 1991... AUTHORS: A. Andre, P. Pavel Houdek, James G. Schwade, Vincent Pisciotta, Christopher F. Serago, Arnold M. Markoe, Bernd-Uwe Sevin, Alan A. Lewin, Beatrice E. Amendola, Xiaodong Wu, Alfred H. Brandon and Keith W. Blackman. University of Miami...

Comparisons of surgery and radiation therapy for non-small cell carcinoma of lung (NSCCL) with mediastinal metastasis (N2MO). (Research Report)
January 21, 1991... AUTHORS: M. Durci, R. Komaki, M.J. Oswald and C.F. Mountain. M.D. Anderson Cancer Center, Houston, Tex. According to the authors' abstract of a presentation to the American Society for Therapeutic Radiology and Oncology, held in Miami,...

Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. (Periodical Report)
January 21, 1991... SOURCE: The New England Journal of Medicine, January 3, 1991; 1(324):1-8. Tumor angiogenesis appears to be a valuable predictor of future metastasis in early breast cancer patients, according to a report by a group of Harvard Medical...

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. (Periodical Report)
January 21, 1991... SOURCE: Journal of the National Cancer Institute, January 16, 1991; 83(2):97-104. In a phase I trial involving patients with inoperable squamous cell lung cancer the monoclonal antibody MAb 225 showed no distinct toxic effect at doses...

Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. (Periodical Report)
January 21, 1991... SOURCE: Cancer, January 1, 1991; 67(1):7-13. Women with ductal carcinoma in situ (DCIS) of the breast treated with breast conservation surgery require careful monitoring for long periods, as tumor recurrence typically occurs following...

Phase I clinical and pharmacokinetic trial of flavone acetic acid. (antitumor agent) (Periodical Report)
January 21, 1991... SOURCE: Journal of the National Cancer Institute, January 16, 1991; 83(2):124-128. A phase I trial of the synthetic benzopyrone derivative flavone acetic acid (FAA) suggests an optimum treatment schedule of 8 g/m2 once weekly for four...

Investigation of electromagnetic radiation supported by Southern California Edison. (U.S. Environmental Protection Agency)
January 28, 1991... U.S. EPA The controversial U.S. Environmental Protection Agency (EPA) report suggesting electromagnetic fields (also called electric and magnetic fields, electromagnetic radiation, electromagnetic frequencies, or EMF) may cause cancer...

Research explores electricity-cancer link. (Electric Power Research Institute)
January 28, 1991... Electric Power Research Institute The Electric Power Research Institute is conducting research in Massachusetts in a simulated neighborhood to explore the potential electricity-cancer link. "If we have a problem here, we need to...

Study of phenacetin raises questions about acetaminophen (Tylenol). (analgesic drugs and cancer) (Switzerland)
January 28, 1991... Switzerland A New England Journal of Medicine (NEJM) study of phenacetin found higher cancer rates among users, and according to a University of Pennsylvania medical professor, the study now raises questions about acetaminophen (Tylenol...

Human papilloma virus widespread among women. (University of California, Berkeley)
January 28, 1991... University of California, Berkeley Human papilloma virus, HPV, a sexually transmitted virus causing genital warts and potentially increasing the risk of cancer, is highly common among women, according to a report in the Journal of the...

Patient accrual better in high-priority trials. (U.S. National Cancer Institute)
January 28, 1991... U.S. NCI So-called high priority trials are accruing patients at well above the average rate of other phase III trials, according to a National Cancer Institute (NCI) report. Established in 1988, the high-priority status is designed...

Prostate cancer deaths increase among blacks in Southeast U.S. (U.S. National Cancer Institute)
January 28, 1991... U.S. NCI Black men living in south Atlantic states appeared to have an increase in prostate cancer mortality during the 1970s, compared to blacks living elsewhere in the U.S., according to the U.S. National Cancer Institute's newly...

New orphan drug named. (TLC G-65 for Mycobacterium avium-intracellular infection) (The Liposome Company Inc.)
January 28, 1991... The Liposome Company, Inc. The Princeton, N.J., drug manufacturer Liposome Company, Inc. has announced that TLC G-65, a gentamicin liposome injection for the treatment of disseminated mycobacterium avium intracellular (MAI) infection,...

Use of skin flaps recommended for repair after melanoma surgery. (Skin Cancer Foundation)
January 28, 1991... Skin Cancer Foundation Cosmetic repair of defects resulting from surgical excision of a melanoma lesion should utilize skin flaps to achieve the best possible cosmetic result, according to a report in The Melanoma Letter, a publication...

Knoll Pharmaceuticals appointed Canadian distributor of DIDRONEL I.V. Infusion. (drug to treat hypercalcemia of malignancy) (MGI Pharma)
January 28, 1991... MGI Pharma MGI Pharma, Inc. announced that Knoll Pharmaceuticals Canada (Knoll Canada), a unit of BASF K&F Canada Inc., will be its exclusive distributor of DIDRONEL I.V. Infusion in Canada. Knoll Canada presently markets...

Printed circuit board wash to be discontinued by NEC. (trichloroethane) (Japan)
January 28, 1991... Japan Trichloroethane will no longer be used by NEC Corp., Tokyo, Japan, after 1995. The chemical is used to wash printed circuit boards and is believed to cause cancer and harm the ozone layer. An international environmental...

Companies challenge Burroughs Wellcome AZT patent. (Apotex Inc. and other companies, zidovudine) (Canada)
January 28, 1991... Canada A recent patent challenge in the Federal Court of Canada could be the first step toward lowering AZT drug treatment costs for AIDS patients worldwide. AZT (zidovudine), which is exclusively manufactured by the pharmaceutical...

New equipment provides safest radiation treatment available. (linear accelerator) (Cleveland Clinic Foundation)
January 28, 1991... Cleveland Clinic The Cleveland Clinic Foundation, Cleveland, Ohio, is the first Greater Cleveland hospital to install computerized linear accelerator equipment that helps to provide cancer patients with the safest radiation treatment...

Cray Research supercomputer ordered for cancer research. (University of Texas)
January 28, 1991... University of Texas Cray Research, Inc., Minneapolis, Minnesota, announced that the University of Texas System has installed a CRAY Y-MP8 system and a solid state storage device, with a total system value of approximately $20.4 million....

Grant awarded to Case Western Reserve Medical School. (and to Ireland Cancer Center at University Hospitals of Cleveland, OH.) (U.S. National Cancer Institute)
January 28, 1991... U.S. NCI The U.S. National Cancer Institute (NCI) has awarded a $5,451,725 grant to a team of eight physicians and scientists at the Case Western Reserve University (CWRU) School of Medicine and the Ireland Cancer Center at University...

New refrigerants to replace chlorofluorocarbons. (Suva) (Du Pont Co.)
January 28, 1991... Du Pont Co. In order to prevent ozone layer depletion, the du Pont Co., Wilmington, Delaware, is introducing a new line of refrigerants to replace chlorofluorocarbons (CFCs), a cooling gas found in Freon. The new products will be...

Mercy Hospital plans new facility for oncology. (Pittsburgh)
January 28, 1991... Pittsburgh Mercy Hospital, Pittsburgh, Pennsylvania, plans to build a five-story $20.5 million oncology facility. Opening is scheduled for spring 1993, and will include chemical and radiation therapy and other oncology services. ...

Montgomery's Agent Orange bill hailed. (Rep. G.V. "Sunny" Montgomery) (Veterans of Foreign Wars of the United States)
January 28, 1991... Veterans of Foreign Wars of the United States The National Commander-in-Chief of the 2.1 million member Veterans of Foreign Wars, James L. Kimery of Albuquerque, N.M., expressed his deep satisfaction and offered his sincere thanks to G.V....